ANNAPOLIS, Md., July 22, 2015 (GLOBE NEWSWIRE) -- In a historic turn of events, Greenway Consultations in Annapolis, Maryland has become the first organization in the state and will begin to see patients on June 17th, the opening day of the clinic. Greenway Consultations is now accepting patients looking to begin the process of becoming a medical marijuana patient in the recently established Maryland Medical Marijuana State Program and furthermore to establish the bonafide patient-doctor relationship, required by Maryland state law. Greenway Consultations will connect patients with qualified and compassionate medical professionals, who will guide them to a more modern and holistic approach with medical marijuana. Greenway Consultations is conveniently located in close proximity to the Annapolis Veterans Administration Center and in a state of the art facility. The office neighbors the cities of Arnold, Severna Park, and Bowie, and but can also serve any legal Maryland residents. MarijuanaDoctors.com is pleased to introduce and welcome Greenway Consultations as its first Maryland doctor to join our nationwide legal network of physicians in the medical marijuana industry.
Greenway Consultations is making every effort and striving to ensure that the qualification and enrollment process into the Maryland Medical Marijuana State Program is quick, simple, and as easy as possible for all potential patients interested in applying for the program. The expert team at Greenway Consultations will also provide information and advice on medical marijuana strain recommendation and the various methods of consumption of medical marijuana at the time of the evaluation appointment.
The highly qualified, professional and discreet medical doctors at Greenway Consultations are available to compassionately guide and assist patients with a wide variety of ailments and medical backgrounds that qualify for the medical marijuana program. Under House Bill 811, the Maryland Medical Marijuana State Program, allows state certified physicians to legally certify and recommend medical marijuana to patients, who have been diagnosed with a chronic or debilitating disease or medical conditions that result in the patient being admitted into hospice or receiving palliative care; a chronic or debilitating disease or medical condition or are receiving treatment for a chronic or debilitating disease or medical condition that causes Cachexia; Anorexia; Wasting Syndrome; Severe Nausea; Seizures; Severe or Persistent Muscle Spasms; Severe or Chronic Pain. Additionally, patients diagnosed with Glaucoma, or Post-Traumatic Stress Disorder (PTSD) also qualify for the state's medical marijuana program under the most recent draft regulation.
Greenway Consultations is also working to re-educate the community about the potential benefits of marijuana as an alternative healthcare option. By means of education campaigns, Greenway Consultations intends to re-inform the community about the true health benefits behind cannabis, while keeping community members updated on the current state of the Maryland Medical Marijuana Program. They will be hosting monthly meetings, and all will also be inviting local businesses such as dispensaries, grow sites, botanical grow stores, hydroponic shops and head shops, to speak and will hold education demonstrations. For more information on upcoming events please visit our website at www.greenwayconsults.com for meeting dates and times.
Greenway Consultations promises to help patients navigate through this new and exciting program for patients. They also provide guidance for the step-by-step process of becoming a medical marijuana patient and in obtaining a Maryland Medical Marijuana Card, while staying compliant with state laws and regulations. This service was created with the vision of serving the current and future medical marijuana patients of Maryland. Greenway Consultations is aspiring to provide Maryland residents with as many options and alternatives as possible when faced with coping with their day-to-day ailments.
For inquiries related to this article or for requests for interviews, please contact: Carlos Valderrama (213) 261-4862 firstname.lastname@example.org
Source: The Medical Cannabis Network